Macrophage-driven inflammation in acute kidney injury: Therapeutic opportunities and challenges
Translational Research · 2025
DOI: 10.1016/j.trsl.2025.02.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Research, 2025. Verfasst von Ya-Fan Mu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Institute of Nephrology, Tianjian Laboratory of Ad…. Hauptthemen laut MEDLINE: Acute Kidney Injury, Macrophages, Inflammation. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: The First Affiliated Hospital of Zhengzhou University, National Natural Science Foundation of China, Henan Province Natural Science Foundation.
Abstract (Originalsprache)
Acute kidney injury (AKI) is increasingly being recognized as a systemic disorder associated with significant morbidity and mortality. AKI manifests with extensive cellular damage, necrosis, and an intense inflammatory response, often leading to late-stage interstitial fibrosis. Although the mechanisms underlying renal injury and repair remain poorly understood, macrophages (pivotal inflammatory cells) play central roles in AKI. They undergo polarization into pro-inflammatory and anti-inflammatory phenotypes, contributing dynamically to both the injury and repair processes while maintaining homeostasis. Macrophages modulate microenvironmental inflammation by releasing extracellular vesicles (EVs) containing pro- or anti-inflammatory signaling molecules, thereby influencing the regulation of tissue injury. The injured tissue cells release EVs and activate local macrophages to initiate these responses. Our bibliometric analysis indicated that a shift has occurred in AKI macrophage research towards therapeutic strategies and clinical translation, focusing on macrophage-targeted therapies, including exosomes and nanoparticles. This review highlights the roles and mechanisms of macrophage activation, phenotypic polarization, and trans-differentiation in AKI and discusses macrophage-based approaches for AKI prevention and treatment. Understanding the involvement of macrophages in AKI contributes to the comprehension of related immune mechanisms and lays the groundwork for novel diagnostic and therapeutic avenues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Institute of Nephrology, Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou University, Zhengzhou, China; He…
Förderung
- The First Affiliated Hospital of Zhengzhou University
- National Natural Science Foundation of China
- Henan Province Natural Science Foundation
Zitieren
APA
Mu, Y. F., Mao, Z. H., Pan, S. K., Liu, D. W., Liu, Z. S., Wu, P., & Gao, Z. X. (2025). Macrophage-driven inflammation in acute kidney injury: Therapeutic opportunities and challenges. Translational Research. https://doi.org/10.1016/j.trsl.2025.02.003
Vancouver
Mu YF, Mao ZH, Pan SK, Liu DW, Liu ZS, Wu P, et al. Macrophage-driven inflammation in acute kidney injury: Therapeutic opportunities and challenges. Translational Research. 2025. doi:10.1016/j.trsl.2025.02.003
BibTeX
@article{Mu2025,
author = {Mu, Ya-Fan and Mao, Zi-Hui and Pan, Shao-Kang and Liu, Dong-Wei and Liu, Zhang-Suo and Wu, Peng and Gao, Zhong-Xiuzi},
title = {Macrophage-driven inflammation in acute kidney injury: Therapeutic opportunities and challenges},
journal = {Translational Research},
year = {2025},
doi = {10.1016/j.trsl.2025.02.003}
}
EUVIMED